Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - Vansen Pharma Inc. | vnsn_8k.htm |
EXHIBIT 16.1
October 25, 2013
Office of the Chief Accountant
Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
We have read Item 4.01 included in the Form 8-K dated October 10, 2013 of Vansen Pharma, Inc..(fka Okana Ventures, Inc.) to be filed with the Securities and Exchange Commission and are in agreement with the statements related to our firm.
Sincerely,
MaloneBailey, LLP
Houston, Texas
www.malone-bailey.com